3

3

SEC Filing Details

Document Details

Form
Filing Date
Sep 20, 2018
Document Date
Sep 20, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.
Filer
Buschle Michael